Biotech & Life Sciences
Growth-stage biotech, sustainable materials, and life sciences platforms, where scientific validation meets institutional capital.
Sector overview
Biotech and life sciences financing rewards preparation. Investors underwrite scientific validation, regulatory pathways, and commercialization milestones alongside team quality. Cross-border capital, government co-funding, and strategic partnerships increasingly shape growth-stage rounds.
Recent deals
- Sustainable bioplastics platform, cross-border capital raise with government co-funding
- Growth-stage therapeutics company, Series B institutional round
- Life sciences tools business, strategic partnership and minority investment
Capital trends
- Strategic partnerships and licensing complementing equity in growth rounds
- Government co-funding and grant validation strengthening institutional processes
- Investor focus on regulatory milestones and capital-efficient development plans
How we help
- Capital raising for growth-stage biotech and sustainable materials companies
- Strategic partnership and licensing advisory
- Investor mapping across specialist funds, strategics, and sovereign capital